Develops and manufactures reinforcing carbons for tires and industrial rubber products. Produces specialty carbons for inks, coatings, plastics, and adhesives. Now — the numbers.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
This is an established company with proven profits.
The gap is $957M. In times of high interest rates, a gap like that can squeeze a company.
The market pays 12.4× for every dollar of annual profit — cheap, which is either an opportunity or a warning.
Against companies in its own sector, it looks cheaper than 76% of them.
Analysts' average target sits 18% above today's price.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly above the class average — a step short of the very top.
A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.
Clearly above the class average — a step short of the very top.
There is growth, but not at top-of-the-class tempo.
The price is looking for direction — no strong breakout, no collapse.
No real weak spot in any of the five subjects — a balanced report card.
The stock trades 32% below its peak. The market has trimmed its expectations for the company.
Over the last 12 months, company executives reported 64 buys and 15 sells. Management buying with its own money is usually read as a good sign.
It pays out $1.85 per share each year — regular cash for whoever holds the stock.
Over the last 4 years, sales grew only 2% a year on average. At this size, speeding back up is not easy.
The share set aside for the future is small; the pace of new ideas may slow.
On our five-subject report card, CBT sits near the top of the class. A high grade doesn’t mean “guaranteed win” — it means “the evidence looks strong for now.”
The takeaway: CBT is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.